3Budenz DL, Radcliffe N, Blumenthal EZ. Late onset blet leakage [J]. J Glaucoma,2009,18(3) :265-267. 被引量：1
4Eigin U, Berker N, Batman A,et al. Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma[J]. J Glaucoma, 2006, 15 (5) :466- 470. 被引量：1
5Macarie S,Palko Z.Therapeutic difficulties in neovascular glaucoma[J].Ophthalmologia,2006,50(2):73-76. 被引量：1
6Poltorak Z,Cohen T,Neufeld G.The VEGF splice variants:properties,receptors,and usage for the treatment of ischemic diseases[J].Herz,2000,25(2):126-129. 被引量：1
7Cohen AF Van Bronswijk H.New Medications:bevacizumab[J].Ned Ti-jdschr Geneeskd,2006,150(40):2194-2195. 被引量：1
8Vatavuk Z,Bencic G,MandicZ.Intravitreal Bevacizumab for neovascular glaucoma following centralretinalarteryocclusion[J].EurJOphthal-mol,2007,17(2):269-271. 被引量：1
9Moshfeghi AA,Rosenfeld PJ,Puliafito CA,et al.Systemic bevacizumab(Avastin)therapy for neovascular age-related macular degeneration:twenty-four-week results of an uncontrolled open-label clinical study[J].Ophthalmology,2006,113(11):1-12. 被引量：1
10Schuman J S,Jacobson J J,Peuliafito C A,et al.Experimental use of semiconductor diode laser in conetact transseleral cyclophotocoaqulation in rabbits[J].Arch Ophthalmol,1990,108(8):1 152-1 157. 被引量：1
